Literature DB >> 17392562

Beta-cell function in severely obese type 2 diabetic patients: long-term effects of bariatric surgery.

Stefania Camastra1, Melania Manco, Andrea Mari, Aldo V Greco, Silvia Frascerra, Geltrude Mingrone, Ele Ferrannini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17392562     DOI： 10.2337/dc06-1845

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  22 in total

1.  A comparison of a personal series of biliopancreatic diversion and literature data on gastric bypass help to explain the mechanisms of resolution of type 2 diabetes by the two operations.

Authors:  Nicola Scopinaro; Francesco Papadia; Giovanni Camerini; Giuseppe Marinari; Dario Civalleri; Adami Gian Franco
Journal:  Obes Surg       Date:  2008-05-08       Impact factor: 4.129

2.  Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery.

Authors:  Mousumi Bose; Julio Teixeira; Blanca Olivan; Baani Bawa; Sara Arias; Sriram Machineni; F Xavier Pi-Sunyer; Philipp E Scherer; Blandine Laferrère
Journal:  J Diabetes       Date:  2010-03       Impact factor: 4.006

3.  Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.

Authors:  S Camastra; A Gastaldelli; A Mari; S Bonuccelli; G Scartabelli; S Frascerra; S Baldi; M Nannipieri; E Rebelos; M Anselmino; E Muscelli; E Ferrannini
Journal:  Diabetologia       Date:  2011-05-26       Impact factor: 10.122

4.  Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes.

Authors:  Fernanda Filgueira Hirsch; Jose Carlos Pareja; Sylka Rodovalho Geloneze; Elinton Chaim; Everton Cazzo; Bruno Geloneze
Journal:  Obes Surg       Date:  2012-06       Impact factor: 4.129

5.  Metabolic Outcomes of Laparoscopic Diverted Sleeve Gastrectomy with Ileal Transposition (DSIT) in Obese Type 2 Diabetic Patients.

Authors:  Alper Celik; Surendra Ugale; Hasan Ofluoglu; Erol Vural; Eylem Cagiltay; Huseyin Cat; Muharrem Asci; Bahri Onur Celik
Journal:  Obes Surg       Date:  2015-11       Impact factor: 4.129

6.  Differential Acute Impacts of Sleeve Gastrectomy, Roux-en-Y Gastric Bypass Surgery and Matched Caloric Restriction Diet on Insulin Secretion, Insulin Effectiveness and Non-Esterified Fatty Acid Levels Among Patients with Type 2 Diabetes.

Authors:  Felicity Thomas; Greg C Smith; Jun Lu; Richard Babor; Michael Booth; Grant Beban; J Geoffrey Chase; Rinki Murphy
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

7.  Can Roux-en-Y gastric bypass provide a lifelong solution for diabetes mellitus?

Authors:  Abdulzahra Hussain; Hind Mahmood; Shamsi El-Hasani
Journal:  Can J Surg       Date:  2009-12       Impact factor: 2.089

8.  Twenty-four hour insulin secretion and beta cell NEFA oxidation in type 2 diabetic, morbidly obese patients before and after bariatric surgery.

Authors:  S Salinari; A Bertuzzi; A Iaconelli; M Manco; G Mingrone
Journal:  Diabetologia       Date:  2008-05-06       Impact factor: 10.122

9.  Feasibility of a supervised inpatient low-calorie diet program for massive weight loss prior to RYGB in superobese patients.

Authors:  Sergio Huerta; Zhaoping Li; Thomas Anthony; Edward H Livingston
Journal:  Obes Surg       Date:  2009-10-28       Impact factor: 4.129

10.  Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function.

Authors:  Ana Carolina Junqueira Vasques; José Carlos Pareja; Maria da Saúde de Oliveira; Fernanda Satake Novaes; Marcelo Miranda Oliveira Lima; Élinton A Chaim; Francesca Piccinini; Chiara Dalla Man; Claudio Cobelli; Bruno Geloneze
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.